You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 5, 2024

CLINICAL TRIALS PROFILE FOR DIGOXIN PEDIATRIC


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Digoxin Pediatric

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000476 ↗ Digitalis Investigation Group (DIG) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1990-06-01 To determine if digitalis had a beneficial, harmful, or no effect on total mortality in patients with clinical heart failure and sinus rhythm.
NCT00000547 ↗ Enalapril After Anthracycline Cardiotoxicity Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1994-04-01 To determine if the chronic administration of enalapril, an inhibitor of angiotensin converting enzyme (ACE), reduces progression of cardiac dysfunction in pediatric oncology patients who have received anthracyclines, and who are not currently on digoxin, diuretics, or vasodilators for heart failure.
NCT00000556 ↗ Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1995-03-01 To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Digoxin Pediatric

Condition Name

Condition Name for Digoxin Pediatric
Intervention Trials
Healthy 36
Atrial Fibrillation 16
Healthy Volunteers 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Digoxin Pediatric
Intervention Trials
Atrial Fibrillation 24
Heart Failure 22
Heart Diseases 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Digoxin Pediatric

Trials by Country

Trials by Country for Digoxin Pediatric
Location Trials
United States 173
Germany 22
Canada 18
Japan 12
United Kingdom 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Digoxin Pediatric
Location Trials
Texas 24
Florida 13
California 12
Ohio 11
New York 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Digoxin Pediatric

Clinical Trial Phase

Clinical Trial Phase for Digoxin Pediatric
Clinical Trial Phase Trials
Phase 4 25
Phase 3 18
Phase 2/Phase 3 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Digoxin Pediatric
Clinical Trial Phase Trials
Completed 135
Not yet recruiting 26
Recruiting 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Digoxin Pediatric

Sponsor Name

Sponsor Name for Digoxin Pediatric
Sponsor Trials
Boehringer Ingelheim 14
Bristol-Myers Squibb 11
AstraZeneca 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Digoxin Pediatric
Sponsor Trials
Other 173
Industry 146
NIH 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.